Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AZEK
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 13.71 3.40 2.99
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -48.16 4.24 8.18
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 3.14 9.52 9.23
Cash -16.34 1.56 1.87
Capex -9.76 -0.13 -0.12
Free Cash Flow -1.19 -0.23 -0.23
Revenue 75.91 2.87 1.63
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -1.28 0.38 0.38
Operating Margin 255.90 0.18 0.05
ROA 97.28 0.02 0.01
ROE 93.92 0.04 0.02
ROIC 709.50 0.03 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AZEK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AZEK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AZEK is permitted for members.